Cargando…
FSMP-02. CHANGES IN GLUTAMINE METABOLISM INDUCED BY OXALOACETATE IN GLIOBLASTOMA
Anhydrous Enol-Oxaloacetate (AEO) has been shown to significantly increase survival and decrease tumor growth rates in animal models of glioblastoma and hepatocellular carcinoma. In the body, AEO is metabolized to “oxaloacetate” (OAA). Earlier, we demonstrated that AEO drastically reduced Warburg gl...
Autores principales: | Ijare, Omkar, Conway, David, Cash, Alan, Baskin, David, Pichumani, Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992272/ http://dx.doi.org/10.1093/noajnl/vdab024.067 |
Ejemplares similares
-
FSMP-19. SEX DIFFERENCES IN REDOX REGULATION UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA
por: Sponagel, Jasmin, et al.
Publicado: (2021) -
FSMP-14. METABOLIC SYMBIOSIS IN GLIOBLASTOMA: LACTATE DEHYDROGENASES TAKE THE LEAD
por: Guyon, Joris, et al.
Publicado: (2021) -
FSMP-12. A ROLE FOR PROLINE BIOSYNTHESIS IN HYPOXIC GLIOBLASTOMA
por: Vettore, Lisa, et al.
Publicado: (2021) -
The Leloir Cycle in Glioblastoma: Galactose Scavenging and Metabolic Remodeling
por: Sharpe, Martyn A., et al.
Publicado: (2021) -
FSMP-11. TARGETING CHOLESTEROL HOMEOSTASIS DYSREGULATION FOR THE TREATMENT OF GLIOBLASTOMA
por: Han, Mingzhi
Publicado: (2021)